Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies

被引：4
|
作者：
机构：
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2012年 / 229卷 / 05期
关键词：
aged-related macular degeneration; anti-VEGF therapy; treatment strategy; OPTICAL COHERENCE TOMOGRAPHY; THICKNESS MEASUREMENTS; RANIBIZUMAB; VERTEPORFIN; INSTRUMENTS; EYES; AMD;
D O I：
10.1055/s-0031-1299392
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：541 / 547
页数：7
相关论文
共 50 条
  • [31] Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
    Pfau, Maximilian
    Sahu, Soumya
    Rupnow, Rawan Allozi
    Romond, Kathleen
    Millet, Desiree
    Holz, Frank G.
    Schmitz-Valckenberg, Steffen
    Fleckenstein, Monika
    Lim, Jennifer, I
    de Sisternes, Luis
    Leng, Theodore
    Rubin, Daniel L.
    Hallak, Joelle A.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (07):
  • [32] Vitreomacular Interface in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration
    Onen, Mehmet
    Kayhan, Ayse Metin
    Yazar, Zeliha
    Ucgun, Nil Irem
    Sarikatipoglu, Hikmet
    OPHTHALMOLOGICA, 2014, 232 : 11 - 11
  • [33] Anti-VEGF agents for age-related macular degeneration
    Ozkiris, Abdullah
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (01) : 103 - 118
  • [34] Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
    Pauleikhoff, Laurenz
    Ziegler, Martin
    Bachmeier, Isabel
    Yu, Siqing
    Armendariz, Beatriz Garcia
    Pauleikhoff, Daniel
    BMC OPHTHALMOLOGY, 2025, 25 (01)
  • [35] Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
    Fu, Yingbin
    Zhang, Zhao
    Webster, Keith A.
    Paulus, Yannis M.
    BIOMOLECULES, 2024, 14 (03)
  • [36] Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
    Campa, C.
    Harding, S. P.
    CURRENT DRUG TARGETS, 2011, 12 (02) : 173 - 181
  • [37] VEGF levels in serum and the outcome of intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Abedi, Farshad
    Wickremasinghe, Sanjeewa
    Islam, Amirul
    Guymer, Robyn H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [38] Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy
    Moreno, S. Flores
    Paloma, J. Bautista
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (06) : 866 - 867
  • [39] ANTI-VEGF DRUGS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - A SYSTEMATIC REVIEW OF THE IMPACT OF ANTI-VEGF THERAPY ON REDUCING BLINDNESS AND VISUAL IMPAIRMENT
    Carrasco, J.
    Pantiri, K.
    VALUE IN HEALTH, 2019, 22 : S597 - S597
  • [40] Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
    Gao, Yang
    Yu, Tao
    Zhang, Yue
    Dang, Guangfu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 4307 - 4317
12345